ASXC News and Press, Asensus Surgical Inc Com From 05/04/22

Asensus Surgical Inc. (ASXC) Q1 2022 Earnings Conference Call May 4, 2022 16:30 ET Company Participants Mark Klausner - Westwicke Partners, Investor Relations Anthony Fernando - President & Chief Executive Officer Shameze Rampertab - Executive Vice President & Chief Financial Officer ...

Shares of Asensus Surgical (NYSE:ASXC) fell 4% in after-hours trading after reporting Q1 2022 revenue that fell below consensus estimates. Net loss widened ~10% year over year to $19.1M, but still beat consensus. Revenue of ~$1.07M in the quarter was a ~49% drop from Q1 2021. Revenu...

Asensus Surgical press release (NYSE:ASXC): Q1 Non-GAAP EPS of -$0.07 beats by $0.01. Revenue of $1.07M (-48.6% Y/Y) misses by $0.23M. The Company had cash, cash equivalents, short-term and long-term investments, excluding restricted cash, of approximately $118.5 million at March 31, 2022. Du...

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced its operating and financial results for the first quarter 2022. R...

Asensus Surgical , Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™, announced today that it plans to release 2022 first quarter financial and operating re...

Asensus Surgical is leading the digital surgical market with Performance-Guided Surgery(TM) New York, New York--(Newsfile Corp. - April 20, 2022) - PCG Digital -- Surgery can be unpredictable, and a staggering one in five patients undergoing surgery has one, or even multiple, preventable surg...

Asensus Surgical (NYSE:ASXC) has filed for a $150M mixed shelf offering. The filing does not necessarily indicate that a sale has begun, or will occur in the future. The company intends to use the proceeds for working capital and general corporate purposes, including R&D, commerciali...

Asensus Surgical Inc. (ASXC) Q4 2021 Results Conference Call February 28, 2022 4:30 PM ET Company Participants Anthony Fernando - CEO Shameze Rampertab - CFO Conference Call Participants Mark Klausner - Westwicke Swayampakula Ramakanth - H.C. Wainwright Ross Osborn - Cantor Fitzgerald Present...

Asensus Surgical press release (NYSE:ASXC): Q4 Non-GAAP EPS of -$0.07. Revenue of $2.48M (+123.4% Y/Y). Shares +2%. For further details see: Asensus Surgical Non-GAAP EPS of -$0.07, revenue of $2.48M

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced its operating and financial results for the fourth quarter and full yea...